Detalles de la búsqueda
1.
Cognitive and Cerebrospinal Fluid Alzheimer's Disease-related Biomarker Trajectories in Older Surgical Patients and Matched Nonsurgical Controls.
Anesthesiology
; 140(5): 963-978, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38324729
2.
Perioperative changes in neurocognitive and Alzheimer's disease-related cerebrospinal fluid biomarkers in older patients randomised to isoflurane or propofol for anaesthetic maintenance.
Br J Anaesth
; 131(2): 328-337, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271721
3.
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
Alzheimers Dement
; 18(8): 1484-1497, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34845818
4.
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
Mov Disord
; 36(12): 2945-2950, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480363
5.
Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study.
Br J Anaesth
; 127(6): 917-928, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34535274
6.
Corrigendum to 'Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study' (Br J Anaesth 2021; 127: 917-928).
Br J Anaesth
; 130(5): 646, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878808
7.
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
Acta Neuropathol
; 131(6): 935-49, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27021906
8.
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
Alzheimers Dement
; 11(7): 772-91, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26194312
9.
Plasma phosphorylated tau181 predicts cognitive and functional decline.
Ann Clin Transl Neurol
; 10(1): 18-31, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36518085
10.
Improved protocol for measurement of plasma ß-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients.
Alzheimers Dement
; 8(4): 250-60, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748936
11.
Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors.
JAMA Netw Open
; 5(10): e2235068, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201209
12.
Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers.
Ann Clin Transl Neurol
; 9(2): 155-170, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35104057
13.
The global Alzheimer's Association round robin study on plasma amyloid ß methods.
Alzheimers Dement (Amst)
; 13(1): e12242, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34692980
14.
Effect of escitalopram dose and treatment duration on CSF Aß levels in healthy older adults: A controlled clinical trial.
Neurology
; 95(19): e2658-e2665, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32913021
15.
High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
Ther Drug Monit
; 31(6): 717-26, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19809389
16.
Derivation of cutoffs for the Elecsys® amyloid ß (1-42) assay in Alzheimer's disease.
Alzheimers Dement (Amst)
; 10: 698-705, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30426066
17.
Qualification of a surrogate matrix-based absolute quantification method for amyloid-ß42 in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.
J Alzheimers Dis
; 41(2): 441-51, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24625802
18.
Association of cerebrospinal fluid ß-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
JAMA Neurol
; 70(10): 1277-87, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23979011
Resultados
1 -
18
de 18
1
Próxima >
>>